What is the recommended cefuroxime axetil dosing regimen for an 87-year-old patient with a creatinine clearance (GFR) of 27 mL/min?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Recommended Cefuroxime Axetil Dosing for GFR 27 mL/min

For an 87-year-old patient with a GFR of 27 mL/min, cefuroxime axetil should be dosed at 250 mg twice daily, or alternatively 500 mg once daily, with the standard individual dose given every 12 hours.

Dosing Rationale Based on Renal Function

The FDA label for cefuroxime axetil does not provide specific renal dosing adjustments for the oral formulation 1. However, research evidence directly addresses this clinical scenario:

Key pharmacokinetic study findings:

  • A study examining cefuroxime axetil in patients with varying renal function established that modification of the dosing schedule is not necessary when creatinine clearance is above 50 mL/min/1.73 m² 2
  • For creatinine clearance of 30-49 mL/min/1.73 m² (which includes your patient with GFR 27), the standard individual dose should be given every 12 hours 2
  • The serum half-life increases from 1.4 hours in normal renal function to approximately 4.6 hours when creatinine clearance is 15-49 mL/min 2

Practical Dosing Recommendations

Standard dosing options for GFR 27 mL/min:

  • 250 mg every 12 hours - appropriate for most infections
  • 500 mg every 12 hours - for more severe infections or less susceptible organisms

The twice-daily interval maintains adequate drug exposure while accounting for the prolonged elimination in moderate-to-severe renal impairment 2.

Important Clinical Considerations

Elderly patient factors:

  • A study of elderly patients (mean age 83.9 years) with mean creatinine clearance of 34.9 mL/min showed a mean serum elimination half-life of 3.5 hours 3
  • Despite lower elimination in geriatric patients, the FDA label states that dosage adjustment based on age alone is not necessary 1
  • However, renal function-based adjustment remains essential

Monitoring recommendations:

  • The prolonged half-life (approximately 4-5 hours at this GFR level) means drug accumulation is possible with standard dosing
  • Watch for adverse effects, particularly diarrhea (11% incidence in clinical trials) and gastrointestinal disturbances 1
  • Several cephalosporins can trigger seizures in patients with renal impairment when dosage is not reduced 1

Common Pitfalls to Avoid

  • Do not use standard dosing (500 mg twice daily) without considering renal function - this risks drug accumulation and toxicity
  • Do not rely on serum creatinine alone - elderly patients often have "normal" creatinine despite significant GFR reduction due to decreased muscle mass
  • Do not extend the interval beyond 12 hours for GFR 27 unless creatinine clearance drops below 10 mL/min (where 24-hour intervals are appropriate) 2

The evidence consistently supports 12-hourly dosing at this level of renal function, balancing efficacy against the risk of accumulation 2, 3.

Related Questions

What is the appropriate cefuroxime dosing regimen for adults and children, including adjustments for renal impairment?
What are the recommended dosing regimens for cefuroxime combined with clavulanic acid in adults and children, and how should the dose be adjusted for impaired renal function?
Can cefuroxime be administered to a patient with an estimated glomerular filtration rate of 46 mL/min/1.73 m²?
What is the recommended cefuroxime (Ceftin) dosing for a renal‑transplant patient with stable graft function, based on creatinine clearance?
What are the indications, recommended dosing regimens, contraindications, and precautions for cefuroxime (cefuroxime axetil) in adults and children?
What are the indications, dosing regimen, administration timing, and storage recommendations for neutral protamine Hagedorn (NPH) insulin?
Is a copper intrauterine device that appears rotated 90 degrees on pelvic ultrasound concerning, and does it require removal or any intervention?
What adjustments to EPAP, pressure support, and mask fit should be made for a patient on adaptive servo‑ventilation (ASV) with current settings of EPAP 4–10 cmH₂O, pressure support 0–10 cmH₂O, who is experiencing excessive sweating, dyspnea, air leak after two hours, and mask intolerance?
Is β-hydroxy β-methylbutyrate (HMB) supplementation contraindicated in patients with a history of arterial stenosis, atherosclerosis, and a stenotic heart valve?
What is the recommended treatment for vasovagal syncope?
What is the recommended treatment regimen for colitis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.